RxDoctor Payments Data

Christina Webb, MD

Family Medicine · Scott Depot, WVNPI 1801000633

Payments from drug & device makers

$3,880in general payments, 2019–2025

Across 260 payments — averaging $14.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$548
  • Abbott$455
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$178
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$149
  • Exact Sciences$130
  • plus $1K from 29 others

What the payments were for

  • Food & beverage$3,880100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,880 in reported general payments places this provider in the 85th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$2,736
Medicare patients
61
Services billed
193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban94$104,778
OzempicSemaglutide62$98,528
MounjaroTirzepatide46$64,118
JanuviaSitagliptin Phosphate59$50,618
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$47,153
JardianceEmpagliflozin39$46,855
XifaxanRifaximin13$38,705
TradjentaLinagliptin33$33,408
LinzessLinaclotide23$22,962
VraylarCariprazine Hcl17$13,805
Tresiba Flextouch U-200Insulin Degludec12$11,980
BrilintaTicagrelor22$11,811
VascepaIcosapent Ethyl15$8,962
Albuterol Sulfate HfaAlbuterol Sulfate154$7,692
DapagliflozinDapagliflozin Propanediol14$7,205

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$52$104,77894 claims
Novo NordiskOzempic$548$98,52862 claims
Boehringer IngelheimJardiance, Tradjenta$15$80,26372 claims
Lilly USA, LLCMounjaro$109$64,11846 claims
MerckJanuvia$69$50,61859 claims
GSKTrelegy Ellipta$122$47,15335 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$149$38,70513 claims
AbbVieLinzess, Vraylar, Synthroid$1,149$38,52658 claims
AstraZenecaBrilinta, Symbicort$40$16,84037 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Scott Depot

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →